INS and COVID-19: The alterations in the glucose–insulin axis in COVID-19 patients with or without comorbidities, suggest that it is very important to control the glycemic state using different drugs such as the metformin, which improves IR and peripheral glucose uptake through the activation of AMP-dependent protein kinase [45].